Bio-Gene Technology Ltd. (AU:BGT) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Bio-Gene Technology Ltd. has announced the cessation of 2.5 million options due to the expiry on May 6, 2024. These options, under the code BGTAK, were not exercised or converted by their expiration date. The company provided this update in a recent filing, underscoring a change in its issued capital structure.
For further insights into AU:BGT stock, check out TipRanks’ Stock Analysis page.